FUSION PHARMACEUTICALS INC's ticker is FUSN and the CUSIP is 36118A100. A total of 41 filers reported holding FUSION PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,543,342 | -44.3% | 3,670,516 | 0.0% | 3.52% | -34.0% |
| Q2 2023 | $17,141,310 | +23.9% | 3,670,516 | 0.0% | 5.32% | +18.2% |
| Q1 2023 | $13,837,845 | +119583.8% | 3,670,516 | 0.0% | 4.50% | +33.8% |
| Q4 2022 | $11,562 | -99.9% | 3,670,516 | 0.0% | 3.36% | +3.5% |
| Q3 2022 | $11,048,000 | +20.9% | 3,670,516 | 0.0% | 3.25% | +39.2% |
| Q2 2022 | $9,140,000 | -68.0% | 3,670,516 | 0.0% | 2.34% | -56.7% |
| Q1 2022 | $28,520,000 | +86.3% | 3,670,516 | 0.0% | 5.39% | +209.5% |
| Q4 2021 | $15,306,000 | -47.3% | 3,670,516 | 0.0% | 1.74% | -31.7% |
| Q3 2021 | $29,070,000 | – | 3,670,516 | – | 2.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,670,516 | $9,543,342 | 3.52% |
| ADAMS STREET PARTNERS LLC | 2,947,809 | $7,664,303 | 2.68% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,560,982 | $4,058,553 | 1.62% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,354,258 | $3,521,071 | 0.64% |
| Avidity Partners Management LP | 5,781,850 | $15,032,810 | 0.60% |
| Eagle Health Investments LP | 579,769 | $1,507,399 | 0.33% |
| Perceptive Advisors | 2,751,395 | $7,153,627 | 0.24% |
| Ghost Tree Capital, LLC | 243,287 | $632,546 | 0.21% |
| Sio Capital Management, LLC | 246,036 | $639,694 | 0.20% |
| Artal Group S.A. | 1,725,000 | $4,485 | 0.19% |